Is 6% Hydroxyethyl Starch 130/0.4 Safe in Coronary Artery Bypass Graft Surgery?
- 1 August 2009
- journal article
- research article
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 17 (4) , 368-372
Abstract
The aim of this study was to compare 6% hydroxyethyl starch 130/0.4 with 4% succinylated gelatin for priming the cardiopulmonary bypass circuit and as volume replacement in patients undergoing coronary artery bypass, in terms of postoperative bleeding, blood transfusion requirements, renal function, and outcome after surgery. Forty-five patients received 6% hydroxyethyl starch 130/0.4 (Voluven) and another 45 were given 4% succinylated gelatin (Gelofusine) as the priming solution for the cardiopulmonary bypass circuit as well as for volume replacement. Postoperative bleeding was quantified from the hourly chest drainage in the first 4 h and at 24 h postoperatively. The baseline characteristics of both groups were similar. In the hydroxyethyl starch group, the total amount of colloid used was 1.9 ± 1.0 L, while the gelatin group had 2.0 ± 0.7 L. There was no significant difference in hourly chest drainage between groups. Blood transfusion requirements, estimated glomerular filtration rate, extubation time, intensive care unit and hospital stay were similar in both groups. It was concluded that 6% hydroxyethyl starch 130/0.4 is a safe alternative colloid for priming the cardiopulmonary bypass circuit and volume replacement in patients undergoing coronary artery bypass surgery.Keywords
This publication has 10 references indexed in Scilit:
- RETRACTED: Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patientsBritish Journal of Anaesthesia, 2008
- Gelatin and Hydroxyethyl Starch, but Not Albumin, Impair Hemostasis After Cardiac SurgeryAnesthesia & Analgesia, 2006
- Hydroxyethyl Starch 130/0.4 Versus Modified Fluid Gelatin for Volume Expansion in Cardiac Surgery Patients: The Effects on Perioperative Bleeding and Transfusion NeedsAnesthesia & Analgesia, 2005
- Large-dose Hydroxyethyl Starch 130/0.4 Does Not Increase Blood Loss and Transfusion Requirements in Coronary Artery Bypass Surgery Compared with Hydroxyethyl Starch 200/0.5 at Recommended DosesAnesthesiology, 2003
- Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patientsJournal of Cardiothoracic and Vascular Anesthesia, 2001
- Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery?Anesthesia & Analgesia, 2000
- Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteersCritical Care Medicine, 1994
- Influence of Different Intravascular Volume Therapies on Platelet Function in Patients Undergoing Cardiopulmonary BypassAnesthesia & Analgesia, 1993
- A Cluster of Severe Postoperative Bleeding following Open Heart SurgeryInfection Control & Hospital Epidemiology, 1992
- Priming solutions for cardiopulmonary bypass: Comparison of three colloidsJournal of Cardiothoracic and Vascular Anesthesia, 1991